Interactive Transcript
0:01
This is a CT scan in a five-year-old boy
0:03
with seizures.
0:04
We can already see several areas
0:06
of calcification, both along the
0:08
margins of the lateral ventricles
0:10
and in the frontal parenchyma.
0:12
Let's look a little closer.
0:14
In addition to these two areas of
0:17
calcification, we're seeing a speck along
0:20
the margin of the frontal horn of the
0:22
left lateral ventricle, along the lateral
0:24
margin of the body of the left lateral
0:26
ventricle, the supralateral margin of
0:28
the body of the right lateral ventricle.
0:30
There's a number of these beyond those.
0:34
calcifications along the margins
0:35
of the lateral ventricle.
0:37
There is this parenchymal calcification here
0:40
at the depth of the sulcus, the gray-white
0:42
differentiation in the left frontal lobe.
0:46
Let's further evaluate this patient
0:48
with MRI, and we can see multiple
0:52
areas of flare hyperintense signal
0:57
throughout both cerebral hemispheres.
1:00
If we look closely at these flare signal
1:02
abnormalities, we can see that there
1:07
is this signal abnormality that tapers
1:09
as it extends into the super lateral
1:12
margin of the lateral ventricles.
1:14
So it's this flare hyperintense
1:15
signal that migrates out and fans
1:20
out as it gets out peripherally.
1:22
We look at another lesion, we'll see it fans.
1:28
Similar here.
1:30
What does that mean?
1:32
Well, these are manifestations
1:34
of tuberous sclerosis complex.
1:36
In particular, these areas here
1:38
are called cortical tubers.
1:40
The bright signal adjacent to the
1:42
tuber is related to dysplastic cells,
1:46
and this area of dysplasia is what's
1:50
referred to as a cortical tuber.
1:54
These cortical tubers.
1:56
Are histologically and radiologically
1:59
identical to what's known as focal cortical
2:02
dysplasia Type II B, which is sometimes
2:04
also referred to as the Taylor type of
2:07
focal cortical dysplasia and also focal
2:10
cortical dysplasia with balloon cells.
2:13
That's because the dysmorphic
2:14
neurons look sort of like balloons.
2:18
These areas of cortical dysplasia
2:20
or cortical tubers on the surface
2:22
look like little protuberances.
2:25
Tubers, and they are firm to the touch.
2:30
First identified on autopsy by Dr.
2:33
Bourneville.
2:34
And so by being firm or rigid, it's sclerosis.
2:38
So these tuberous sclerosis
2:40
comes from this here.
2:43
We often refer to the disease clinically
2:45
as tuberous sclerosis complex because
2:47
it is more than just these areas
2:49
of dysplasia or cortical tubers.
2:51
And we're going to discuss
2:53
some of those differences.
2:57
So we see these multifocal multifocal
3:00
areas of cortical dysplasia
3:02
throughout both cerebral hemispheres.
3:05
Each one of these areas of cortical
3:07
dysplasia is a potential source of a seizure.
3:12
Now, beyond the cortical dysplasia,
3:15
of which this one here is mineralized,
3:18
we have multiple little nodules along
3:20
the margins of the lateral ventricles.
3:23
We can see on T2-weighted image, these two
3:25
nodules here, along the lateral margin of
3:29
the anterior body of both lateral ventricles,
3:31
are hypointense on T2-weighted imaging.
3:34
This T2 hypointensity is related to the
3:37
low water content that we can surmise from
3:39
the mineralization seen on the CT scan.
3:41
Susceptibility weighted imaging shows
3:43
hypointense signal also, which is the
3:46
MR correlate of this mineralization.
3:50
Susceptibility-weighted imaging also shows
3:52
some of these other areas of mineralization,
3:54
including this one along the margin of the
3:56
frontal horn of the left lateral ventricle
3:58
and that area of mineralized dysplasia.
4:02
After giving contrast, we can see that
4:04
surrounding this area of mineralization
4:08
along the lateral margin of the frontal
4:09
horn of the right lateral ventricle,
4:12
there's post-contrast enhancement.
4:15
We can see here there's post
4:17
contrast enhancement, and
4:18
there's a hypo-enhancing area.
4:20
This hypo-enhancing area is likely the
4:22
mineralization because calcium does not have
4:25
blood vessels and therefore does not enhance.
4:29
So we can measure this nodule, and including
4:35
the mineralization, it's approximately
4:37
one centimeter by one centimeter by
4:42
That's approximately six millimeters.
4:45
These nodules, many of which
4:46
demonstrate mineralization, are
4:48
called subependymal nodules.
4:50
They're a key feature of
4:51
tuberous sclerosis complex.
4:54
These nodules may also enhance, but one
4:58
thing to be aware of is that some of
5:00
these nodules, in particular ones along
5:03
the lateral margin of the anterior body
5:05
of the lateral ventricles, can enlarge.
5:08
They enlarge and are clinically referred to
5:11
as a subependymal giant cell astrocytoma.
5:15
That can become a problem if they get
5:17
too big because, as we notice, this
5:19
is adjacent to the foramen of Monroe.
5:23
If this enlarges too much, it can obstruct
5:26
the ipsilateral foramen of Monroe and
5:29
result in obstructive hydrocephalus.
5:33
So if we look at a follow-up study, five years
5:37
later, we can see that this nodule has grown.
5:40
There's still this area of hypo enhancement,
5:43
likely related to mineralization, but the
5:45
surrounding area of tissue, has enlarged.
5:50
It's now at least 15 millimeters.
5:54
Now, at the moment, the ipsilateral
5:56
foramen of Monroe does not appear to be,
5:59
be obstructed, although this is something
6:03
that they want to keep a very close eye on,
6:06
because if there is enlargement to the point
6:09
where there's impending impingement of the
6:10
foramen of Monroe, there are several options.
6:13
Historically, surgical
6:14
resection was the option used.
6:16
More recently, we know that mTOR
6:19
inhibitors mTOR, meaning mammalian
6:22
target of rapamycin, M T O R.
6:24
MTOR inhibitors can actually result
6:28
in involution of the lesions and
6:32
may obviate the need for surgery.
6:35
So this patient has tuberous
6:36
sclerosis complex with a right-sided
6:39
subependymal giant cell astrocytoma.
6:43
Now, it's important to notice that this lesion
6:46
was 10 millimeters and it took over five years
6:49
for it to get large enough that it's even
6:52
getting close to the frame of the Monroe.
6:57
A lot of times there are distinctions
7:00
made that once a lesion reaches 10
7:02
millimeters, it's a subependymal giant
7:04
cell astrocytoma or SEGA, S E G A,
7:08
but That doesn't tell the whole story.
7:12
An eight-millimeter nodule and a
7:14
12-millimeter nodule histologically
7:16
are going to be identical.
7:17
If you give it to the pathologist and don't
7:20
tell them how big it is, they're going
7:21
to call both of them the same, a SEGA.
7:24
So we need to recognize that there's
7:27
a difference between the histological
7:28
diagnosis of the SEGA and the
7:31
clinically relevant diagnosis.
7:33
From a clinically relevant standpoint, people
7:35
have historically said 10 millimeters.
7:38
Recognize, of course, that a lesion
7:40
that has been 11 millimeters for five
7:45
straight years without any growth.
7:47
While it is greater than that 10
7:49
millimeter threshold, likely is
7:52
not of immediate clinical concern.
7:56
Conversely, a lesion that is two millimeters
7:59
that six months later is four millimeters
8:01
that six months later is six millimeters
8:03
that six months later is eight millimeters.
8:06
That's more concerning.
8:07
So even though it hasn't reached
8:08
the 10 millimeter threshold, the
8:10
growth trajectory is actually just as
8:14
clinically relevant as the actual size.
8:16
So beyond just reporting the size of
8:19
a lesion, the growth trajectory, as
8:23
well as the relationship to the foramen
8:24
of Monroe is critically important.
© 2024 Medality. All Rights Reserved.